Two Biologics Evaluated for Facial, Hand, Foot Dermatitis

'Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients,' Dr Jenny Murase said, in reporting results at RAD 2023.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Palo Alto ,California ,Washington ,Oregon ,San Francisco ,University Of Pennsylvania ,American ,Eric Simpson ,Eli Lilly ,Jennye Murase ,Chiesa Fuxench ,Zelma Chiesa Fuxench ,Jonathani Silverberg ,Palo Alto Calf Foundation Medical Group ,American Academy Of Dermatology ,George Washington University ,Science University ,Oregon Health ,University Of California ,European Union ,Regeneron Pharmaceuticals ,Drug Administration ,Revolutionizing Atopic Dermatitis ,Foundation Medical ,New England Journal ,Investigator Global Assessment ,Peak Pruritus Numerical Rating Scale ,Hand Eczema Questionnaire ,American Academy ,Dermatitis ,Monoclonal Antibody ,Etuximab ,Ituximab ,Hands ,Drug Development ,Foot ,Feet ,Facial ,Biologic Therapy ,Adolescent Medicine ,Atopic Dermatitis ,Pruritus ,Pruritis ,Pitch ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Corticosteroid ,Eczema ,Tolerance ,Topical Corticosteroids ,Interleukins ,